Development and Validation of Measures to Evaluate Adolescents' Knowledge About Human Papillomavirus (HPV), Involvement in HPV Vaccine Decision-making, Self-efficacy to Receive the Vaccine and Fear and Anxiety

Overview

Journal Public Health

Publisher Elsevier

Specialty Public Health

Date 2017 Apr 14

PMID 28404501

Citations 22

Authors

A S Forster

K A McBride

C Davies

T Stoney

H Marshall

K McGeechan

S C Cooper

S R Skinner

Affiliations

Soon will be listed here.

Abstract

Objectives: We describe the development and validation of measures of human papillomavirus (HPV)/HPV vaccination knowledge, fear/anxiety about vaccination, involvement in HPV vaccine decision-making, and self-efficacy with regard to getting the vaccine, designed to evaluate the efficacy of an intervention to affect these domains (collectively termed the HAVIQ: HPV Adolescent Vaccine Intervention Questionnaire).

Study Design: Literature search, cognitive interviews and cross-sectional survey.

Methods: A literature search identified existing items that were modified for the present measures. Experts reviewed draft measures for face and content validity. Cognitive interviews with adolescents were also used to assess content validity. Adolescents completed the measures and an internal reliability analysis of each measure was performed.

Results: The four experts concurred that the measures had face validity. Cognitive interviews identified items requiring refinement. Content validity was examined with ten experts and was deemed acceptable. There were 1800 adolescents who completed the measures; Cronbach's alpha was >0.6 for three of the four measures. The four final measures are brief, comprising 25 items in total.

Conclusions: The measures are robustly developed and validity-tested. The HAVIQ may be used in research settings to evaluate adolescents' knowledge and experiences of the process of HPV vaccination in a school-based vaccination programme.

Citing Articles

COVID-19 Vaccine Information Exposure: The Effect of Online Authority vs. Non-Authority Sources on Beliefs, Emotions and Information Engagement Behaviors.

Xu X, Lin C Vaccines (Basel). 2024; 12(10).

PMID: 39460262 PMC: 11511211. DOI: 10.3390/vaccines12101096.

Developing and validating a scale to measure the perceptions of safety, usability and acceptability of microarray patches for vaccination: a study protocol.

Berger M, Davies C, Mathieu E, Shaban R, Bag S, Skinner S Ther Adv Vaccines Immunother. 2024; 12:25151355241263560.

PMID: 39044997 PMC: 11265248. DOI: 10.1177/25151355241263560.

Analysis of influencing factors of HPV vaccination willingness of female sex workers in urban entertainment venues based on the IMB model in Guangxi, China.

He Z, Wei J, Jiang J, Hu R, Qi G BMC Womens Health. 2024; 24(1):141.

PMID: 38402149 PMC: 10893625. DOI: 10.1186/s12905-024-02962-y.

The community nurse's role on the promotion of papillomavirus vaccination among young students: A study protocol.

Simonetti V, Tomietto M, Comparcini D, Pastore F, Stefanizzi P, Tafuri S Hum Vaccin Immunother. 2024; 20(1):2314383.

PMID: 38356279 PMC: 10877978. DOI: 10.1080/21645515.2024.2314383.

Evaluating Human Papillomavirus eHealth in Hmong Adolescents to Promote Vaccinations: Pilot Feasibility Study.

Lee H, Xiong S, Sur A, Khang T, Vue B, Culhane-Pera K JMIR Form Res. 2023; 7:e38388.

PMID: 37338961 PMC: 10337404. DOI: 10.2196/38388.

References

Wisk L, Allchin A, Witt W . Disparities in human papillomavirus vaccine awareness among U.S. parents of preadolescents and adolescents. Sex Transm Dis. 2014; 41(2):117-22. PMC: 4037159. DOI: 10.1097/OLQ.0000000000000086. View

Hughes J, Cates J, Liddon N, Smith J, Gottlieb S, Brewer N . Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev. 2009; 18(2):363-72. DOI: 10.1158/1055-9965.EPI-08-0418. View

Brotherton J . Human papillomavirus vaccination: where are we now?. J Paediatr Child Health. 2014; 50(12):959-65. DOI: 10.1111/jpc.12627. View

Lloyd G, Marlow L, Waller J, Miles A, Wardle J . An experimental investigation of the emotional and motivational impact of HPV information in adolescents. J Adolesc Health. 2009; 45(5):532-4. DOI: 10.1016/j.jadohealth.2009.06.003. View

Wegwarth O, Kurzenhauser-Carstens S, Gigerenzer G . Overcoming the knowledge-behavior gap: The effect of evidence-based HPV vaccination leaflets on understanding, intention, and actual vaccination decision. Vaccine. 2014; 32(12):1388-93. DOI: 10.1016/j.vaccine.2013.12.038. View

de Sanjose S, Quint W, Alemany L, Geraets D, Klaustermeier J, Lloveras B . Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010; 11(11):1048-56. DOI: 10.1016/S1470-2045(10)70230-8. View

Marlow L, Waller J, Evans R, Wardle J . Predictors of interest in HPV vaccination: A study of British adolescents. Vaccine. 2009; 27(18):2483-8. DOI: 10.1016/j.vaccine.2009.02.057. View

Cothran M, White J . Adolescent behavior and sexually transmitted diseases: the dilemma of human papillomavirus. Health Care Women Int. 2002; 23(3):306-19. DOI: 10.1080/073993302317346352. View

Apter D, Wheeler C, Paavonen J, Castellsague X, Garland S, Skinner S . Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial. Clin Vaccine Immunol. 2015; 22(4):361-73. PMC: 4375348. DOI: 10.1128/CVI.00591-14. View

10.

Kahn J, Rosenthal S, Jin Y, Huang B, Namakydoust A, Zimet G . Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol. 2008; 111(5):1103-10. DOI: 10.1097/AOG.0b013e31817051fa. View

11.

Tabrizi S, Brotherton J, Kaldor J, Skinner S, Cummins E, Liu B . Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis. 2012; 206(11):1645-51. DOI: 10.1093/infdis/jis590. View

12.

Bernard D, Cooper Robbins S, McCaffery K, Scott C, Skinner S . The domino effect: adolescent girls' response to human papillomavirus vaccination. Med J Aust. 2011; 194(6):297-300. DOI: 10.5694/j.1326-5377.2011.tb02978.x. View

13.

Robbins S, Bernard D, McCaffery K, Brotherton J, Skinner S . "I just signed": Factors influencing decision-making for school-based HPV vaccination of adolescent girls. Health Psychol. 2010; 29(6):618-25. DOI: 10.1037/a0021449. View

14.

Aubin F, Pretet J, Jacquard A, Saunier M, Carcopino X, Jaroud F . Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV). Clin Infect Dis. 2008; 47(5):610-5. DOI: 10.1086/590560. View

15.

Sotiriadis A, Dagklis T, Siamanta V, Chatzigeorgiou K, Agorastos T . Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine. Arch Gynecol Obstet. 2012; 285(6):1719-24. DOI: 10.1007/s00404-011-2208-z. View

16.

Marteau T, Bekker H . The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol. 1992; 31(3):301-6. DOI: 10.1111/j.2044-8260.1992.tb00997.x. View

17.

Forster A, Waller J, Bowyer H, Marlow L . Girls' explanations for being unvaccinated or under vaccinated against human papillomavirus: a content analysis of survey responses. BMC Public Health. 2015; 15:1278. PMC: 4689042. DOI: 10.1186/s12889-015-2657-6. View

18.

Gerhardt C, Pong K, Kollar L, Hillard P, Rosenthal S . Adolescents' knowledge of human papillomavirus and cervical dysplasia. J Pediatr Adolesc Gynecol. 2000; 13(1):15-20. DOI: 10.1016/s1083-3188(99)00031-5. View

19.

Smith J, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R . Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007; 121(3):621-32. DOI: 10.1002/ijc.22527. View

20.

Batista Ferrer H, Trotter C, Hickman M, Audrey S . Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis. BMC Public Health. 2014; 14:700. PMC: 4100058. DOI: 10.1186/1471-2458-14-700. View